IDENTIFICATION OF COMPLEMENT RESISTANCE DETERMINANTS IN ESCHERICHIA COLI
大肠杆菌中补体抗性决定因素的鉴定
基本信息
- 批准号:3746593
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Certain strains of E. coli causes extraintestinal disease, ranging from
cystitis to sepsis. Complement resistance appears to be a vital trait in
the pathogenesis of infections by these strains. An improved understanding
of the complement resistance determinants in this group of E. coli may to
a logical development of new preventative and/or therapeutic strategies.
The experimental approach taken for this project was to study a serum
resistant, non-K1, blood isolate as a model pathogen; as these serotypes
are responsible for the majority of adult disease caused by extra-
intestinal isolates of E.coli. Transposon mutagenesis (TnphoA) was
utilized to create a library of mutants in outer, periplasmic and
cytoplasmic membrane proteins. Mutants were screened for an increased
sensitivity to serum. Isogenic group 2 (K54 antigen) capsule deficient
mutants were identified with an increased sensitivity to serum, undergoing
a 3-4 log-kill over 3 hours in 80% serum. Further in vitro evaluations
established that the K54 capsular polysaccharide protects against killing
by the alternative complement pathway. In addition, C3 binding was
equivalent in both strains. Therefore, the mechanism of complement
resistance conferred by the K54 capsule is different than that of K1.
The E. coli LPS has been purported to be the major complement resistance
determinant. Therefore, we undertook and were successful in creating
proven isogenic LPS-minus (O specific chain) derivatives of CP9 as well as
isogenic CP9 derivatives deficient in both the group 2 capsule (K54) and
the 0 specific chain of the LPS (04). The results of our evaluations of
these mutants, however, are in contrast to those of previous reports. The
04 antigen appears to play only a minor role in protecting against
complement mediated killing. However, the loss of both the K54 antigen and
the 04 render the strain extremely serum sensitive.The results of these
studies expands on the understanding of complement resistance mechanisms
in E. coli. This project is being terminated at N.I.H.
大肠杆菌的某些菌株会引起肠外疾病,范围从
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
T A RUSSO其他文献
T A RUSSO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('T A RUSSO', 18)}}的其他基金
REGULATION OF CAPSULE SYNTHESIS IN A PATHOGENIC ESCHERICHIA COLI ISOLATE
致病性大肠杆菌分离株中胶囊合成的调控
- 批准号:
3746606 - 财政年份:
- 资助金额:
-- - 项目类别:
IDENTIFICATION OF COMPLEMENT RESISTANCE DETERMINANTS IN ESCHERICHIA COLI
大肠杆菌中补体抗性决定因素的鉴定
- 批准号:
3768848 - 财政年份:
- 资助金额:
-- - 项目类别:
IDENTIFICATION OF COMPLEMENT RESISTANCE DETERMINANTS IN ESCHERICHIA COLI
大肠杆菌中补体抗性决定因素的鉴定
- 批准号:
3803268 - 财政年份:
- 资助金额:
-- - 项目类别:
IDENTIFICATION OF COMPLEMENT RESISTANCE DETERMINANTS IN ESCHERICHIA COLI
大肠杆菌中补体抗性决定因素的鉴定
- 批准号:
3809751 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF CAPSULE SYNTHESIS IN A PATHOGENIC ESCHERICHIA COLI ISOLATE
致病性大肠杆菌分离株中胶囊合成的调控
- 批准号:
3768858 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF CAPSULE SYNTHESIS IN A PATHOGENIC E. COLI ISOLATE
致病性大肠杆菌分离株中胶囊合成的调控
- 批准号:
3790850 - 财政年份:
- 资助金额:
-- - 项目类别:
REGULATION OF CAPSULE SYNTHESIS IN A PATHOGENIC E. COLI ISOLATE
致病性大肠杆菌分离株中胶囊合成的调控
- 批准号:
3803287 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
9884089 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
10438532 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
10553173 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
9275348 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
8965936 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
8245631 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Host, environmental, and bacterial factors associated with animal pathogenic and zoonotic Escherichia coli infections
与动物致病性和人畜共患大肠杆菌感染相关的宿主、环境和细菌因素
- 批准号:
2294-2010 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2007
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual